Market Overview:
The global clinical trial packaging and labelling market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in this market can be attributed to the increasing number of clinical trials, rising demand for patient-centricity in drug development, and growing focus on reducing drug development costs. Based on type, the global clinical trial packaging and labelling market is segmented into kraft paper, corrugated paper, and plastic. Kraft paper is expected to account for the largest share of the global clinical trial packaging and labelling market in 2018 owing to its low cost as well as its ability to protect products from moisture and other environmental factors. Based on application, the global clinical trial packaging and labelling market is segmented into drug manufacturing companies, research labs, contract research organizations (CROs), hospitals & clinics, biotechnology companies & academic institutes/research centres), medical device manufacturers)and others).
Product Definition:
Clinical trial packaging and labelling is the process of preparing and marking clinical trial materials for distribution to study sites. The purpose of Clinical Trial Packaging and Labelling is to ensure that each participant in a clinical trial receives the same dose of study drug, at the same time, every time.
Kraft Paper:
Kraft paper is a cellulose fiber-based, non-toxic, and durable material that acts as a base for the printing of labels and packages. It can be used in direct contact with food products or pharmaceuticals. Kraft paper is manufactured by pulverizing wood flour in an acidic medium (such as sulfuric acid) at high temperature followed by neutralization with alkaline water to produce fibers which are then dried.
Corrugated Paper:
Corrugated paper is a thin cardboard-like material, which is manufactured by the corrugation process. The basic materials used for corrugated paper making include pulp, water and salts. The manufacturing process of corrugated papers involves three steps which are folding & cutting, glazing and drying and lastly scoring & binding to make sure that the final product has high strength along with being able to withstand rough handling during shipping or storage.
Application Insights:
Based on application, the global clinical trial packaging and labelling market is segmented into drug manufacturing companies, research labs, and others. The other segment includes hospitals & healthcare centers as well as private practices. Drug manufacturing companies held the largest share in 2017 due to extensive usage of clinical trials for discovering new drugs with higher efficiency than conventional methods.
The growing importance of data safety during clinical trials coupled with rising concerns regarding product quality are some of the major factors driving this segment growth over the forecast period. For instance, in June 2018 Hyacinth Empowerment Institute launched a new study pack called ¢â‚¬Å“Empowering Women Through Natural Health Care¢â‚¬ which was a double-blind placebo controlled study for evaluating the effect of garlic extract on women's health issues such as menopause symptoms and blood pressure levels.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, well-established healthcare infrastructure and high adoption rate of new technologies in this region. Moreover, increasing R&D activities and rising number of clinical trials are expected to drive the demand for trial packaging materials in North America over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to untapped opportunities, low cost base and increased focus on quality standards by regulatory bodies such as Ministry Of Health And Family Welfare (MoHFW) & Department Of Pharmaceuticals (DoP). Furthermore, an increase in healthcare expenditure coupled with growing penetration of international drug manufacturers into emerging markets such as China and India is further expected boost regional growth over next eight years.
Growth Factors:
- Increasing demand for clinical trials due to the rise in prevalence of chronic diseases
- Growing number of contract research organizations (CROs) and clinical trial centers
- Rising awareness about the benefits of early diagnosis and treatment among patients and healthcare professionals
- Technological advancements in packaging and labeling technologies
- Stringent regulatory framework governing the pharmaceutical industry
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Trial Packaging and Labelling Market Research Report
By Type
Kraft Paper, Corrugated Paper, Plastic
By Application
Drug Manufacturing Companies, Research Labs, Others
By Companies
PCI Pharma Services, Körber Medipak Systems, WestRock, CordenPharma, Sentry BioPharma Services, NextPharma Technologies, Sharp, Fisher Clinical Services, CMS(Clinigen), Symbiosis Pharmaceutical Services, Bilcare GCS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Trial Packaging and Labelling Market Report Segments:
The global Clinical Trial Packaging and Labelling market is segmented on the basis of:
Types
Kraft Paper, Corrugated Paper, Plastic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Manufacturing Companies, Research Labs, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PCI Pharma Services
- Körber Medipak Systems
- WestRock
- CordenPharma
- Sentry BioPharma Services
- NextPharma Technologies
- Sharp
- Fisher Clinical Services
- CMS(Clinigen)
- Symbiosis Pharmaceutical Services
- Bilcare GCS
Highlights of The Clinical Trial Packaging and Labelling Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kraft Paper
- Corrugated Paper
- Plastic
- By Application:
- Drug Manufacturing Companies
- Research Labs
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trial Packaging and Labelling Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical trial packaging and labelling is the process of designing and producing a package or label that accurately reflects the contents of a clinical trial. The goal is to ensure that patients, health care professionals, researchers, and others who are interested in participating in a clinical trial can easily identify which trials are available and understand what they entail.
Some of the major players in the clinical trial packaging and labelling market are PCI Pharma Services, K¶rber Medipak Systems, WestRock, CordenPharma, Sentry BioPharma Services, NextPharma Technologies, Sharp, Fisher Clinical Services, CMS(Clinigen), Symbiosis Pharmaceutical Services, Bilcare GCS.
The clinical trial packaging and labelling market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Trial Packaging and Labelling Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Trial Packaging and Labelling Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Trial Packaging and Labelling Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Trial Packaging and Labelling Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Trial Packaging and Labelling Market Size & Forecast, 2018-2028
4.5.1 Clinical Trial Packaging and Labelling Market Size and Y-o-Y Growth
4.5.2 Clinical Trial Packaging and Labelling Market Absolute $ Opportunity
Chapter 5 Global Clinical Trial Packaging and Labelling Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Trial Packaging and Labelling Market Size Forecast by Type
5.2.1 Kraft Paper
5.2.2 Corrugated Paper
5.2.3 Plastic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Trial Packaging and Labelling Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Trial Packaging and Labelling Market Size Forecast by Applications
6.2.1 Drug Manufacturing Companies
6.2.2 Research Labs
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Trial Packaging and Labelling Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Trial Packaging and Labelling Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Trial Packaging and Labelling Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Trial Packaging and Labelling Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Trial Packaging and Labelling Market Size Forecast by Type
9.6.1 Kraft Paper
9.6.2 Corrugated Paper
9.6.3 Plastic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Trial Packaging and Labelling Market Size Forecast by Applications
9.10.1 Drug Manufacturing Companies
9.10.2 Research Labs
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Trial Packaging and Labelling Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Trial Packaging and Labelling Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Trial Packaging and Labelling Market Size Forecast by Type
10.6.1 Kraft Paper
10.6.2 Corrugated Paper
10.6.3 Plastic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Trial Packaging and Labelling Market Size Forecast by Applications
10.10.1 Drug Manufacturing Companies
10.10.2 Research Labs
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Trial Packaging and Labelling Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Trial Packaging and Labelling Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Trial Packaging and Labelling Market Size Forecast by Type
11.6.1 Kraft Paper
11.6.2 Corrugated Paper
11.6.3 Plastic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Trial Packaging and Labelling Market Size Forecast by Applications
11.10.1 Drug Manufacturing Companies
11.10.2 Research Labs
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Trial Packaging and Labelling Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Trial Packaging and Labelling Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Trial Packaging and Labelling Market Size Forecast by Type
12.6.1 Kraft Paper
12.6.2 Corrugated Paper
12.6.3 Plastic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Trial Packaging and Labelling Market Size Forecast by Applications
12.10.1 Drug Manufacturing Companies
12.10.2 Research Labs
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Trial Packaging and Labelling Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Trial Packaging and Labelling Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Trial Packaging and Labelling Market Size Forecast by Type
13.6.1 Kraft Paper
13.6.2 Corrugated Paper
13.6.3 Plastic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Trial Packaging and Labelling Market Size Forecast by Applications
13.10.1 Drug Manufacturing Companies
13.10.2 Research Labs
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Trial Packaging and Labelling Market: Competitive Dashboard
14.2 Global Clinical Trial Packaging and Labelling Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PCI Pharma Services
14.3.2 Körber Medipak Systems
14.3.3 WestRock
14.3.4 CordenPharma
14.3.5 Sentry BioPharma Services
14.3.6 NextPharma Technologies
14.3.7 Sharp
14.3.8 Fisher Clinical Services
14.3.9 CMS(Clinigen)
14.3.10 Symbiosis Pharmaceutical Services
14.3.11 Bilcare GCS
